Fisetin vs Quercetin for Senolytic Therapy Comparison

Last updated: March 2026

When it comes to senolytic therapy—a cutting-edge approach to combat age-related decline—two natural compounds almost always pop up: fisetin and quercetin. If you’re like me, you’ve probably wondered which one actually deserves your attention and your money. Both are flavonoids found in fruits and vegetables and have been touted for their ability to clear out senescent cells, those “zombie” cells that refuse to die but cause inflammatory havoc. But here’s the kicker: despite their similarities, they operate quite differently in practice.

Having spent years researching longevity interventions and sifting through clinical data, I’ve noticed that the fisetin vs quercetin debate is more nuanced than a simple better/worse split. So, I’ll unpack the latest evidence, practical dosing, side effects, and availability, especially for those of us in the UK looking for sensible ways to implement senolytic therapy. Spoiler: it’s not just about popping supplements—there’s a lot to consider to do this safely and effectively.

What Are Senolytics and Why Do They Matter?

Before diving into fisetin vs quercetin, let’s quickly clarify senolytics. Senolytics are compounds designed to selectively induce death in senescent cells. These cells accumulate as we age, contributing to chronic inflammation, tissue dysfunction, and many age-related diseases. Clearing them out has been shown in animal models to improve healthspan and even lifespan.

I first took a serious interest in senolytic therapy after the seminal 2015 studies by Kirkland et al. demonstrated that a cocktail of dasatinib and quercetin could clear senescent cells and improve function in mice. Since then, natural senolytics like fisetin and quercetin gained popularity because of their accessibility and relatively mild side effect profile compared to pharmaceutical options. For those reading Best Longevity Supplements Backed by Science 2026: Evidence-Based Insights for Healthy Ageing, you’ll know natural senolytics are often a good starting point.

Fisetin: The Rising Star of Senolytic Therapy

Fisetin, a flavonol found in strawberries, apples, and onions, has gained huge traction recently. Honestly, I think it’s the more promising candidate for most people interested in senolytics. The bulk of recent animal studies has shown that fisetin extends lifespan in mice by up to 10-15% when administered intermittently (Yousefzadeh et al., 2018). It also improved markers of kidney function, cognition, and reduced systemic inflammation.

The dose used in these mouse studies typically translates to around 20 mg/kg in humans, roughly 1,500 mg for a 75 kg person. Clinical trials in humans are limited but growing; a small 2019 pilot study at the Mayo Clinic found fisetin was safe and improved inflammatory markers in elderly patients over two days of dosing (ClinicalTrials.gov Identifier: NCT03675724).

One thing I’ve noticed is that fisetin tends to have better bioavailability than quercetin, especially when taken with fat. This makes a difference in real-world use. In the UK, fisetin supplements are becoming more available through reputable sources, although it’s still less common than quercetin.

Typical Practical Dose: 500 mg to 1,000 mg taken intermittently (e.g., 2 consecutive days per month), often with meals containing fat for absorption.

Pros of Fisetin

Strong senolytic activity demonstrated in rodent models
Better bioavailability than quercetin
Shown to reduce inflammation and improve function in early human studies
Generally well-tolerated with few side effects

Cons of Fisetin

Limited large-scale human trials to date
Less widely available as a supplement in the UK than quercetin

Quercetin: The Veteran Flavonoid with Mixed Senolytic Credentials

Quercetin is arguably the more familiar name—it’s been around longer in the supplement world and is found in apples, onions, and capers. It gained a lot of attention after the 2015 study I mentioned earlier, where it was combined with dasatinib to clear senescent cells.

However, quercetin on its own is a bit of a mixed bag. It does have senolytic properties but is less potent than fisetin in many assays. What’s more, it has notoriously poor bioavailability—oral doses often lead to low plasma levels that might limit its effectiveness. That said, formulations with bromelain or other enhancers can improve absorption.

One practical advantage is that quercetin is much easier to get hold of in the UK and is even used off-label in some clinical contexts, sometimes combined with metformin or other longevity drugs. But be cautious: dosages above 1,000 mg daily can sometimes cause mild side effects like headaches or gastrointestinal discomfort.

Typical Practical Dose: 500 mg to 1,000 mg daily, sometimes combined with vitamin C or bromelain to enhance absorption, usually taken intermittently in senolytic protocols.

Pros of Quercetin

Well-studied antioxidant, anti-inflammatory profile
Available widely and cheaply in the UK
Used in combination therapies (e.g., with dasatinib)

Cons of Quercetin

Lower senolytic potency compared to fisetin
Poor bioavailability unless formulated specially
Potential mild side effects at higher doses
Often requires combination with other agents to maximize effect

Fisetin vs Quercetin: How Do They Stack Up?

To make this clearer, here’s a comparison table summarising key points from clinical data, pharmacology, and practical usage:

Aspect	Fisetin	Quercetin
Source Foods	Strawberries, apples, onions	Apples, onions, capers
Senolytic Potency	High (shown lifespan extension in mice)	Moderate (better in combination)
Bioavailability	Better, fat enhances absorption	Poor, improved with bromelain or vitamin C
Typical Human Dose	500-1,000 mg intermittently	500-1,000 mg daily or intermittent
Side Effects	Rare, mild (GI discomfort occasionally)	Mild headaches, GI issues at higher doses
Availability (UK)	Increasing, less common	Widely available
Human Clinical Trials	Limited but promising (e.g., Mayo Clinic)	More data but mainly in combination therapies

Safety, Interactions, and Practical Considerations

Now here’s the thing about senolytics like fisetin and quercetin: they’re generally safe when used intermittently in moderate doses but not without precautions. Both supplements can interact with medications metabolised by the liver (especially involving CYP450 enzymes). For example, quercetin can affect blood thinners and certain chemotherapeutics.

Given the NHS’s cautious stance on supplements, I always recommend discussing with your GP before starting any new regimen—especially if you’re on medications or have underlying health issues. You can also find out more about your baseline health and ageing markers with Best Blood Tests for Longevity Biomarkers UK in 2026.

As for practical use, most protocols recommend intermittent dosing—say, 2 consecutive days per month—to mimic the senolytic cycles seen in animal studies. Chronic daily dosing hasn’t been well-studied and might carry risks of off-target effects. And despite their natural origin, these compounds aren’t a substitute for lifestyle factors like diet, exercise, or avoiding smoking.

So, Which One Should You Choose?

Honestly, if I had to pick one for senolytic therapy based on the current evidence, it’d be fisetin. Its superior potency and bioavailability give it a clear edge, especially if you’re aiming for longevity benefits beyond generic antioxidant support. That said, quercetin still has its place, particularly in combination therapies or if fisetin isn’t readily available.

For those interested in combinatory approaches, you might even consider cycling between them or using quercetin with agents like dasatinib (prescribed by specialists). Just don’t overdo it—senolytic therapy is about precision, not megadosing.

If you want to explore other longevity compounds alongside senolytics, you may find the following articles useful:

FAQ: Fisetin vs Quercetin for Senolytic Therapy

Are fisetin and quercetin safe for long-term use?

Both are generally safe when taken intermittently at recommended doses. Long-term daily use hasn’t been extensively studied, so caution is advised. Always consult your healthcare provider before starting any new supplement regimen.

Can I take fisetin or quercetin alongside prescription medications?

These flavonoids can interact with medications metabolised by liver enzymes and may affect blood clotting. It’s essential to discuss this with your doctor, especially if you’re taking blood thinners, statins, or chemotherapy drugs.

What’s the best dosing schedule for senolytic effects?

Most studies suggest intermittent dosing—such as 2 consecutive days per month—to effectively clear senescent cells while minimising side effects. Continuous daily dosing is not generally recommended without medical supervision.

Is fisetin available on the NHS or as a prescription?

Currently, fisetin is not licensed as a prescription drug in the UK and is not available on the NHS. It’s available as a supplement through some health stores and online retailers but always choose reputable brands to ensure quality.

How does fisetin compare to other senolytic agents like dasatinib?

Dasatinib is a prescription cancer drug with potent senolytic activity but higher risk of side effects. Fisetin offers a natural, safer alternative but with somewhat lower potency. Some protocols combine dasatinib with quercetin for synergistic effects, but this should only be done under medical supervision.

Final Thoughts

In the fisetin vs quercetin matchup for senolytic therapy, fisetin comes out ahead for me—mainly because of its stronger evidence base and better bioavailability. But both compounds hold value, especially as part of a holistic approach to healthy ageing that includes diet, exercise, and smart supplementation. Remember, though: more isn’t always better. Keeping doses moderate and intermittent, along with professional guidance, is key.

If you’re looking for supplements that target other ageing mechanisms, I recommend checking out my guides on NAD+ vs NMN and Peptides for Longevity 2026 Latest Research for a broader perspective.

Stay curious, stay cautious, and here’s to ageing well!

References:

Yousefzadeh MJ et al., “Fisetin is a senotherapeutic that extends health and lifespan,” EBioMedicine, 2018.
ClinicalTrials.gov NCT03675724, “Pilot Study of Fisetin in Older Adults,” Mayo Clinic.
Kirkland JL et al., “The Clinical Potential of Senolytic Drugs,” J Am Geriatr Soc, 2017.

For more on related longevity approaches, don’t miss the articles on telomere lengthening supplements and metformin for anti-ageing.

And for a deeper dive into pharmacological longevity options, see my expert review on rapamycin dosage and side effects.

Finally, if you want a trustworthy external reference on flavonoids and health effects, the NIH PubMed Central article on flavonoids is an excellent resource.